reference/16585878

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16585878

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	6
issn	0008-5472
issueIdentifier	7
pageRange	1520-6
publicationName	Cancer research
startingPage	1520
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_266f09c09d1e3aa97cbfe9240f44f32b
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9398e637563d71237dbee4a1a1858b1d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cb675369299e7e6dac3b9b1508c777f8
bibliographicCitation	Yang B, Keshelava N, Anderson CP, Reynolds CP. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine. Cancer Res. 2003 Apr 01;63(7):1520–6. PMID: 12670899.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d15c06e3f5353bd789b21c193102875 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9fe762b7a99c1016c8094c5b84d57a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_892f25429ad51282805a84c5bfec081f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0cb9e2836c090dd0845edc2ac4e945c2
date	2003-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/12670899
isPartOf	https://portal.issn.org/resource/ISSN/0008-5472 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2786
language	English
source	https://pubmed.ncbi.nlm.nih.gov/
title	Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine
discusses	http://id.nlm.nih.gov/mesh/M0028777 http://id.nlm.nih.gov/mesh/M0021908 http://id.nlm.nih.gov/mesh/M0026397 http://id.nlm.nih.gov/mesh/M0009388 http://id.nlm.nih.gov/mesh/M0142901 http://id.nlm.nih.gov/mesh/M0015671
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014227Q000494 http://id.nlm.nih.gov/mesh/D000971Q000494 http://id.nlm.nih.gov/mesh/D009447Q000188 http://id.nlm.nih.gov/mesh/D009447Q000378 http://id.nlm.nih.gov/mesh/D019328Q000037 http://id.nlm.nih.gov/mesh/D010100Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D007425Q000187 http://id.nlm.nih.gov/mesh/D000077704 http://id.nlm.nih.gov/mesh/D008564Q000502 http://id.nlm.nih.gov/mesh/D008564Q000187 http://id.nlm.nih.gov/mesh/D007425Q000502 http://id.nlm.nih.gov/mesh/D015687Q000502 http://id.nlm.nih.gov/mesh/D005978Q000378 http://id.nlm.nih.gov/mesh/D014407 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D019328Q000494 http://id.nlm.nih.gov/mesh/D008928Q000502 http://id.nlm.nih.gov/mesh/D008928Q000187 http://id.nlm.nih.gov/mesh/D019328Q000008 http://id.nlm.nih.gov/mesh/D004357 http://id.nlm.nih.gov/mesh/D017382Q000378 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D014227Q000008
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.8.1.7 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65359 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135413511 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6914 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21157 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6254 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8646 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f8548e8d07a64a93d1c3be34e2340799 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12035

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129192846 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128977994 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135788062 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127946759

Total number of triples: 68.